Low-dose Liposomal Amphotericin B for Antifungal Prophylaxis in Prolonged Neutropenia Patients
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Chronic Lymphocytic Leukemia
Related studies linked through entity extraction aliases.
Study of Zanubrutinib in Older Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Epcoritamab Plus Venetoclax Plus Ibrutinib in Patients With Chronic Lymphocytic Leukemia With TP53 Alterations
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Venetoclax Plus Zanubrutinib for the Treatment of Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Atrial Fibrillation Among Patients With Hematologic Malignancies on Tyrosine Kinase Inhibitor Therapy
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Nemtabrutinib With Venetoclax and Obinutuzumab in Patients With Chronic Lymphocytic Leukemia
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
BAFF CAR-T Cells (LMY-922) for Treatment of Refractory Hematologic Malignancies
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Phase 2 Trial Of The Combination Of Zanubrutinib, Sonrotoclax, And Obinutuzumab For Patients With Treatment-Naïve Chronic Lymphocytic Leukemia
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Tafasitamab With Acalabrutinib and Venetoclax for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Nemtabrutinib and Venetoclax for the Treatment of Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Study on Treatment Outcome Patterns for Patients With CLL After Discontinuation of BTK Inhibitors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLL
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Long-Term Follow-Up of AvenCell Sponsored CAR-T Cell Clinical Trials
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
variaTIon in Referral Thresholds in the Chronic Lymphocytic LeukaEmia Pathway
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
This Clinical Trial is a Single-arm, Non-randomized Pilot Trial to Determine the Safety of Administering Autologous Anti-C19 Cells (ARI-0001) and the Feasibility of Local CAR-T Cell Production in Patients Over 18 Years of Age With Relapsed/Refractory (R/R) CD19+ Hematologic Malignancies, Including R
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
- Status
- RECRUITING
- Phase
- PHASE3
Observ Prosp Study of Acalabrutinib in CLL Therapy in Real Clinical Practice in Belarus
- Status
- RECRUITING
- Phase
- N/A
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
- Status
- RECRUITING
- Phase
- PHASE3
A Study of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) in Participants With Chronic Lymphocytic Leukemia (CLL) and Other B-cell Malignancies
- Status
- RECRUITING
- Phase
- PHASE2